GHRP-2
Price range: $49.00 through $99.00 USD
GHRP-2 is a synthetic hexapeptide from the growth-hormone-releasing peptide family. Supplied for in-vitro laboratory research. Each lot is supplied with its own Certificate of Analysis.
| Form and size | Lyophilized vial |
- Certificate of Analysis for every lot
- HPLC and mass spectrometry testing for every lot
- Lot number on every vial and report
- Protective, discreet packaging
Description
About this material
GHRP-2 is a synthetic hexapeptide from the growth-hormone-releasing peptide family. MICROGRAMBIO supplies GHRP-2 as a lyophilized powder in a sealed vial for in-vitro laboratory research. Each lot comes with its own Certificate of Analysis, so you can check the identity and the results for the exact vial you receive.
Research context
In the laboratory literature, GHRP-2 is discussed in work on ghrelin-receptor (GHS-R) signalling and growth-hormone secretion pathways in cell-based assays. Researchers use it as a tool to examine these systems in cell-based and other in-vitro models.
Published work comes from many laboratories that use different models, methods and conditions, and a result in one system does not carry over to another. Nothing on this page describes an effect in people or animals. Review the primary literature when you design your own study.
Research focus
- Ghrelin-receptor (GHS-R) signalling
- Growth-hormone secretion pathways in cell-based assays
- Receptor-binding studies of the GHRP family
What you receive
- A sealed vial of lyophilized powder, in the size you choose above
- A Certificate of Analysis for the lot, with the testing methods and results
- A lot number printed on the vial and on the report
- Protective, discreet packaging
Handling and documentation
Follow the storage instructions on the label and on the report for your lot, together with your laboratory's own procedures. Keep the vial sealed until you need it, and record the lot number, the date you received it and your storage conditions in your laboratory notes. If you need help reading the report, use the guides below or contact us with your order and lot numbers.
Related reading
How to read a peptide Certificate of Analysis · HPLC explained · Storage and handling basics
Specifications
| Size | 5 mg, 10 mg, 15 mg, 20 mg |
|---|---|
| Material type | Peptide |
| Form | Lyophilized powder in a sealed vial |
| Storage | As stated on the label and the report for your lot |
For laboratory research use only. Not for human or animal consumption.
Key features
- Certificate of Analysis supplied for every lot
- Testing methods and results listed on the lot report
- Lot number printed on the vial and on the report
- Supplied as a sealed lyophilized vial
- Four vial sizes: 5, 10, 15 and 20 mg
- Protective, discreet packaging
- For laboratory research use only
How this lot of GHRP-2 is verified
Identity
Mass spectrometry measures the molecular weight of the material so you can confirm the compound in the vial matches the label.
Purity
HPLC shows how much of the sample is the target peptide. The result is written into the report for your lot.
Documentation
The Certificate of Analysis is tied to your lot number. Compare it with the label before you use the material. See our testing process.
Storage and handling
Follow the storage instructions on the label and on the report for your lot, together with your laboratory's own procedures. As general laboratory practice, lyophilized material is kept sealed, dry, protected from light and cold. Record dates and conditions in your laboratory notes.
Questions about GHRP-2
Is GHRP-2 for human or animal use?
No. GHRP-2 is supplied for laboratory research use only. It is not a drug, is not for human or animal consumption, and is not intended to diagnose, treat, cure or prevent any condition.
Where do I find the lot number and report?
The lot number is printed on the vial label. The Certificate of Analysis for the current lot is linked on this page, and your order confirmation and account show the lot you received.
How is GHRP-2 tested?
Each lot is analysed using HPLC for purity and mass spectrometry for identity, and the results are written into the report for that lot.
Who can buy GHRP-2?
Qualified researchers and laboratories aged 21 or over. You confirm this when you enter the site and again at checkout.
Where do you ship?
Delivery options and countries are shown at checkout.
More answers on our FAQ page.






Amanda Johnson –
Exceptional dual protocol. Using GHRP-2 in conjunction with HGH 191AA maximized total trial efficiency. GHRP-2 was key for delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, and HGH 191AA ensured enhancing cellular regeneration, collagen synthesis, lean muscle preservation, and joint resilience. The batch purity report matched our independent verification completely.
Samuel Thompson –
Combining GHRP-2 with Semaglutide has proven to be one of the most effective protocols in our catalog. GHRP-2 effectively handles delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while Semaglutide works in tandem to ensure effectively reducing appetite, suppressing cravings, and improving glycemic metrics. Consistent potency and exceptional quality.
Shirley Campbell –
This combination of GHRP-2 and Tirzepatide exceeded expectations in our trial run. The inclusion of GHRP-2 was vital for delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while Tirzepatide amplified overall outcomes by delivering powerful weight loss, insulin sensitivity improvements, and metabolic regulation. Packaging arrived cold and intact, and batch testing confirmed supreme quality.
Nancy White –
Integrating GHRP-2 alongside CagriSema (Cagrilintide + Semaglutide Combo) in our testing protocol yielded exceptional synergy. GHRP-2 provided reliable support for delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while CagriSema (Cagrilintide + Semaglutide Combo) complemented the protocol perfectly by targeting dual satiety and hunger pathways for potent, comprehensive body weight management. Both reconstitute cleanly and show outstanding stability. Highly recommended for advanced research.
Sharon Mitchell –
Stacking GHRP-2 and Cagrilintide provides a complete, well-rounded protocol. GHRP-2 acts as a baseline by delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, whereas Cagrilintide adds synergistic value through promoting early satiety, delaying gastric emptying, and reducing food cravings independently of GLP-1. Both vials dissolved effortlessly without residue.
Stephanie Morgan –
Combining GHRP-2 with Sermorelin has proven to be one of the most effective protocols in our catalog. GHRP-2 effectively handles delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while Sermorelin works in tandem to ensure stimulating natural pituitary GH output, enhancing recovery quality, supporting deep sleep, and overall vitality. Consistent potency and exceptional quality.
David Smith –
Our research team ran a 4-week protocol testing GHRP-2 together with Ipamorelin. The results were noticeable from week one: GHRP-2 targeted delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while Ipamorelin enhanced overall effectiveness by providing clean, selective growth hormone release without elevating cortisol, prolactin, or appetite. Very clean product line and fast shipping.
Shirley Ortiz –
This combination of GHRP-2 and CJC-1295 (With DAC) exceeded expectations in our trial run. The inclusion of GHRP-2 was vital for delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while CJC-1295 (With DAC) amplified overall outcomes by sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life. Packaging arrived cold and intact, and batch testing confirmed supreme quality.
Debra Jones –
Exceptional dual protocol. Using GHRP-2 in conjunction with Liraglutide maximized total trial efficiency. GHRP-2 was key for delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, and Liraglutide ensured supporting daily blood glucose stabilization, appetite control, and sustained weight management. The batch purity report matched our independent verification completely.
Stephen Lewis –
Combining GHRP-2 with Tesamorelin has proven to be one of the most effective protocols in our catalog. GHRP-2 effectively handles delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while Tesamorelin works in tandem to ensure targeting visceral abdominal fat reduction, stimulating endogenous growth hormone release, and elevating IGF-1. Consistent potency and exceptional quality.
Nicole Ramirez –
Combining GHRP-2 and CJC-1295 (No DAC) created a remarkable dual-action response. We observed clean activation where GHRP-2 excelled at delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, and CJC-1295 (No DAC) stepped in to deliver providing sharp, physiological growth hormone pulses when paired with a growth hormone secretagogue. The purity of both compounds was top-notch with zero unexpected side effects.
Robert Martinez –
If you are looking to stack complementary peptides, pairing GHRP-2 with Dulaglutide is an absolute winner. GHRP-2 shines for delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, and when stacked with Dulaglutide, you gain the additional benefit of providing long-acting glycemic control, metabolic stability, and appetite reduction. Reconstitution was smooth and instantaneous.
David Taylor –
Exceptional dual protocol. Using GHRP-2 in conjunction with Tirzepatide maximized total trial efficiency. GHRP-2 was key for delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, and Tirzepatide ensured delivering powerful weight loss, insulin sensitivity improvements, and metabolic regulation. The batch purity report matched our independent verification completely.
Margaret Moore –
Our research team ran a 4-week protocol testing GHRP-2 together with CagriSema (Cagrilintide + Semaglutide Combo). The results were noticeable from week one: GHRP-2 targeted delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while CagriSema (Cagrilintide + Semaglutide Combo) enhanced overall effectiveness by targeting dual satiety and hunger pathways for potent, comprehensive body weight management. Very clean product line and fast shipping.
Jeffrey Martin –
Stacking GHRP-2 and CJC-1295 (No DAC) provides a complete, well-rounded protocol. GHRP-2 acts as a baseline by delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, whereas CJC-1295 (No DAC) adds synergistic value through providing sharp, physiological growth hormone pulses when paired with a growth hormone secretagogue. Both vials dissolved effortlessly without residue.
Maria Green –
Exceptional dual protocol. Using GHRP-2 in conjunction with Hexarelin maximized total trial efficiency. GHRP-2 was key for delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, and Hexarelin ensured inducing rapid growth hormone pulses, supporting cardiac muscle health, and accelerating physical recovery. The batch purity report matched our independent verification completely.
Heather Allen –
Integrating GHRP-2 alongside CJC-1295 + Ipamorelin Blend in our testing protocol yielded exceptional synergy. GHRP-2 provided reliable support for delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while CJC-1295 + Ipamorelin Blend complemented the protocol perfectly by maximizing pulsatile growth hormone secretion via dual receptor pathway co-activation. Both reconstitute cleanly and show outstanding stability. Highly recommended for advanced research.
Karen Adams –
If you are looking to stack complementary peptides, pairing GHRP-2 with Semaglutide is an absolute winner. GHRP-2 shines for delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, and when stacked with Semaglutide, you gain the additional benefit of effectively reducing appetite, suppressing cravings, and improving glycemic metrics. Reconstitution was smooth and instantaneous.
Elizabeth Williams –
Combining GHRP-2 with Retatrutide + Cagrilintide Combo has proven to be one of the most effective protocols in our catalog. GHRP-2 effectively handles delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while Retatrutide + Cagrilintide Combo works in tandem to ensure delivering unmatched weight loss, appetite suppression, and metabolic energy balance. Consistent potency and exceptional quality.
Richard Wilson –
Our research team ran a 4-week protocol testing GHRP-2 together with MOTS-c. The results were noticeable from week one: GHRP-2 targeted delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while MOTS-c enhanced overall effectiveness by promoting AMPK activation, metabolic balance, cellular energy production, and exercise capacity. Very clean product line and fast shipping.
Timothy Morales –
Combining GHRP-2 and Cagrilintide created a remarkable dual-action response. We observed clean activation where GHRP-2 excelled at delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, and Cagrilintide stepped in to deliver promoting early satiety, delaying gastric emptying, and reducing food cravings independently of GLP-1. The purity of both compounds was top-notch with zero unexpected side effects.
Robert Rivera –
Combining GHRP-2 and Mazdutide created a remarkable dual-action response. We observed clean activation where GHRP-2 excelled at delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, and Mazdutide stepped in to deliver driving significant body weight reduction and optimizing glycemic control markers. The purity of both compounds was top-notch with zero unexpected side effects.
Michelle White –
Integrating GHRP-2 alongside Survodutide in our testing protocol yielded exceptional synergy. GHRP-2 provided reliable support for delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while Survodutide complemented the protocol perfectly by boosting energy expenditure, promoting liver fat clearance, and controlling caloric intake. Both reconstitute cleanly and show outstanding stability. Highly recommended for advanced research.
Jason Garcia –
Our research team ran a 4-week protocol testing GHRP-2 together with CJC-1295 + Ipamorelin Blend. The results were noticeable from week one: GHRP-2 targeted delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while CJC-1295 + Ipamorelin Blend enhanced overall effectiveness by maximizing pulsatile growth hormone secretion via dual receptor pathway co-activation. Very clean product line and fast shipping.
Eric Jackson –
Combining GHRP-2 and GHRP-6 created a remarkable dual-action response. We observed clean activation where GHRP-2 excelled at delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, and GHRP-6 stepped in to deliver strongly stimulating growth hormone release while boosting appetite signaling and digestive motility. The purity of both compounds was top-notch with zero unexpected side effects.
Deborah Rogers –
Exceptional dual protocol. Using GHRP-2 in conjunction with CJC-1295 (With DAC) maximized total trial efficiency. GHRP-2 was key for delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, and CJC-1295 (With DAC) ensured sustaining elevated baseline growth hormone and IGF-1 levels over an extended multi-day half-life. The batch purity report matched our independent verification completely.
Karen Martin –
Stacking GHRP-2 and Mazdutide provides a complete, well-rounded protocol. GHRP-2 acts as a baseline by delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, whereas Mazdutide adds synergistic value through driving significant body weight reduction and optimizing glycemic control markers. Both vials dissolved effortlessly without residue.
Diane Morales –
If you are looking to stack complementary peptides, pairing GHRP-2 with Retatrutide + Cagrilintide Combo is an absolute winner. GHRP-2 shines for delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, and when stacked with Retatrutide + Cagrilintide Combo, you gain the additional benefit of delivering unmatched weight loss, appetite suppression, and metabolic energy balance. Reconstitution was smooth and instantaneous.
Sarah Wright –
Combining GHRP-2 with Dulaglutide has proven to be one of the most effective protocols in our catalog. GHRP-2 effectively handles delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while Dulaglutide works in tandem to ensure providing long-acting glycemic control, metabolic stability, and appetite reduction. Consistent potency and exceptional quality.
Melissa Edwards –
This combination of GHRP-2 and Liraglutide exceeded expectations in our trial run. The inclusion of GHRP-2 was vital for delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while Liraglutide amplified overall outcomes by supporting daily blood glucose stabilization, appetite control, and sustained weight management. Packaging arrived cold and intact, and batch testing confirmed supreme quality.
George Gomez –
Our research team ran a 4-week protocol testing GHRP-2 together with Survodutide. The results were noticeable from week one: GHRP-2 targeted delivering robust pulsatile growth hormone secretion with a mild appetite stimulation profile, while Survodutide enhanced overall effectiveness by boosting energy expenditure, promoting liver fat clearance, and controlling caloric intake. Very clean product line and fast shipping.